Answer: The use of β-blockers is contraindicated in patients who are at risk for cardiogenic shock low cardiac output and acute heart failure.
A patient with a diagnosis of ACS is experiencing cardiogenic shock. Which adjuvant therapy would be contraindicated?
Thrombolytic drugs…